ISRG实时信号 | 通过Getagraph.com最大化利润

购买 3372 min ago

@ $375.32

发出时间: 27 Apr 2024 @ 03:56

回报率: 0.00%

上一信号: Apr 27 - 00:53

上一信号: 出售

回报率: -0.12 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	927 650
平均成交量	1.53M
市值	133.13B
EPS	$1.600 ( 2024-04-18 )
下一个收益日期	( $1.530 ) 2024-07-18
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	67.63
ATR14	$9.73 (2.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Nachtsheim Jami K	Buy	569	Common Stock
2024-04-25	Nachtsheim Jami K	Buy	739	Restricted Stock Units
2024-04-25	Nachtsheim Jami K	Sell	569	Restricted Stock Units
2024-04-25	Kolli Sreelakshmi	Buy	739	Restricted Stock Units
2024-04-25	Kolli Sreelakshmi	Buy	240	Common Stock

INSIDER POWER
-18.58
Last 100 transactions
Buy: 47 446 \| Sell: 69 887

音量相关性

長: -0.62 (weak negative)

短: -0.86 (strong negative)

Signal:(28) Be Aware. Possible trading coming up! (swing)

Intuitive Surgical Inc 相关性

10 最正相关
LWAC	0.87
LIVX	0.863
MMAC	0.862
RAACW	0.861
RAAC	0.856
AMRB	0.841
JCOM	0.832
UPC	0.832
REYN	0.829
EEIQ	0.809

10 最负相关
FEYE	-0.886
SVAC	-0.87
DTEA	-0.841
SNPO	-0.836
INZY	-0.834
VTYX	-0.833
INSE	-0.833
TRIN	-0.831
SIBN	-0.83
CVCY	-0.828

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Intuitive Surgical Inc 相关性 - 货币/商品

-0.47
( neutral )

-0.69
( moderate negative )

0.00
( neutral )

-0.70
( moderate negative )

0.35
( neutral )

0.49
( neutral )

Intuitive Surgical Inc 财务报表

Annual	2023
营收:	$7.12B
毛利润:	$4.73B (66.39 %)
EPS:	$5.12

FY	2023
营收:	$7.12B
毛利润:	$4.73B (66.39 %)
EPS:	$5.12

FY	2022
营收:	$6.22B
毛利润:	$4.20B (67.44 %)
EPS:	$3.72

FY	2021
营收:	$5.71B
毛利润:	$3.96B (69.32 %)
EPS:	$4.85

Financial Reports:

No articles found.

Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.